Use of CARP inhibitors for the treatment of heart diseases

Details for Australian Patent Application No. 2001295457 (hide)

Owner Merck Patent GmbH

Inventors Zolk, Oliver; Brandle, Marian; Hentsch, Bernd; Kluxen, Franz-Werner; Ehring, Thomas; Eschenhagen, Thomas; Wilm, Claudia

Agent Davies Collison Cave

Pub. Number AU-B-2001295457

PCT Pub. Number WO02/20003

Priority 00119771 11.09.00 EP

Filing date 13 August 2001

Wipo publication date 22 March 2002

Acceptance publication date 16 November 2006

International Classifications

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61K 49/00 (2006.01) Preparations for testing

Event Publications

16 November 2006 Application Accepted

  Published as AU-B-2001295457

15 March 2007 Standard Patent Sealed

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001295458-MFQ-111, a novel human gtpase like protein

2001295456